4//SEC Filing
Dachille Douglas A. 4
Accession 0001209191-23-039352
CIK 0001743881other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:16 PM ET
Size
5.6 KB
Accession
0001209191-23-039352
Insider Transaction Report
Form 4
Dachille Douglas A.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 totalExercise: $16.75Exp: 2033-06-21→ Common Stock (51,501 underlying)
Footnotes (1)
- [F1]1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001652908
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:16 PM ET
- Size
- 5.6 KB